View Future GrowthSANGBO 과거 순이익 실적과거 기준 점검 0/6SANGBO 의 수입은 연평균 -71.8%의 비율로 감소해 온 반면, Chemicals 산업은 연평균 1.1%의 비율로 증가했습니다. 매출은 연평균 19.7%의 비율로 감소해 왔습니다.핵심 정보-71.76%순이익 성장률-71.39%주당순이익(EPS) 성장률Chemicals 산업 성장률13.95%매출 성장률-19.69%자기자본이익률-30.14%순이익률-25.71%최근 순이익 업데이트31 Dec 2025최근 과거 실적 업데이트Reported Earnings • Mar 17Full year 2025 earnings released: ₩229 loss per share (vs ₩191 loss in FY 2024)Full year 2025 results: ₩229 loss per share (further deteriorated from ₩191 loss in FY 2024). Revenue: ₩50.1b (down 6.9% from FY 2024). Net loss: ₩12.9b (loss widened 19% from FY 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 87 percentage points per year, which is a significant difference in performance.Reported Earnings • Mar 14Full year 2024 earnings released: ₩191 loss per share (vs ₩8.00 profit in FY 2023)Full year 2024 results: ₩191 loss per share (down from ₩8.00 profit in FY 2023). Revenue: ₩53.8b (down 19% from FY 2023). Net loss: ₩10.8b (down ₩11.3b from profit in FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 106 percentage points per year, which is a significant difference in performance.Reported Earnings • Aug 17Second quarter 2024 earnings released: EPS: ₩22.00 (vs ₩31.00 in 2Q 2023)Second quarter 2024 results: EPS: ₩22.00 (down from ₩31.00 in 2Q 2023). Revenue: ₩15.5b (down 10% from 2Q 2023). Net income: ₩1.24b (down 31% from 2Q 2023). Profit margin: 8.0% (down from 10% in 2Q 2023). Over the last 3 years on average, earnings per share has fallen by 53% per year but the company’s share price has only fallen by 11% per year, which means it has not declined as severely as earnings.Reported Earnings • Mar 19Full year 2023 earnings released: EPS: ₩8.00 (vs ₩67.43 in FY 2022)Full year 2023 results: EPS: ₩8.00 (down from ₩67.43 in FY 2022). Revenue: ₩66.2b (down 1.9% from FY 2022). Net income: ₩438.5m (down 89% from FY 2022). Profit margin: 0.7% (down from 5.9% in FY 2022). Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings.Reported Earnings • Nov 19Third quarter 2023 earnings released: EPS: ₩44.00 (vs ₩59.03 in 3Q 2022)Third quarter 2023 results: EPS: ₩44.00 (down from ₩59.03 in 3Q 2022). Revenue: ₩17.4b (up 12% from 3Q 2022). Net income: ₩2.53b (down 26% from 3Q 2022). Profit margin: 15% (down from 22% in 3Q 2022). Over the last 3 years on average, earnings per share has fallen by 3% per year but the company’s share price has increased by 11% per year, which means it is well ahead of earnings.Reported Earnings • Mar 14Full year 2022 earnings released: EPS: ₩67.43 (vs ₩82.02 in FY 2021)Full year 2022 results: EPS: ₩67.43 (down from ₩82.02 in FY 2021). Revenue: ₩67.4b (down 6.9% from FY 2021). Net income: ₩4.00b (down 1.6% from FY 2021). Profit margin: 5.9% (up from 5.6% in FY 2021). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 106% per year but the company’s share price has only increased by 24% per year, which means it is significantly lagging earnings growth.모든 업데이트 보기Recent updatesNew Risk • May 19New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 13% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 72% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (13% average weekly change). Market cap is less than US$100m (₩25.5b market cap, or US$16.9m).Reported Earnings • Mar 17Full year 2025 earnings released: ₩229 loss per share (vs ₩191 loss in FY 2024)Full year 2025 results: ₩229 loss per share (further deteriorated from ₩191 loss in FY 2024). Revenue: ₩50.1b (down 6.9% from FY 2024). Net loss: ₩12.9b (loss widened 19% from FY 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 87 percentage points per year, which is a significant difference in performance.공시 • Feb 20SANGBO Corp., Annual General Meeting, Mar 26, 2026SANGBO Corp., Annual General Meeting, Mar 26, 2026, at 09:01 Tokyo Standard Time. Location: auditorium, 50, daeseomyeong-ro, tongjin-eup, gyeonggi-do, gimpo South Korea분석 기사 • Jan 07The Market Lifts SANGBO Corp. (KOSDAQ:027580) Shares 26% But It Can Do MoreSANGBO Corp. ( KOSDAQ:027580 ) shareholders would be excited to see that the share price has had a great month, posting...New Risk • Jan 07New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 9.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 69% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (9.8% average weekly change). Market cap is less than US$100m (₩54.4b market cap, or US$37.6m).분석 기사 • Nov 03Is SANGBO (KOSDAQ:027580) Using Too Much Debt?The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...분석 기사 • Jul 22SANGBO Corp.'s (KOSDAQ:027580) Share Price Could Signal Some RiskThere wouldn't be many who think SANGBO Corp.'s ( KOSDAQ:027580 ) price-to-sales (or "P/S") ratio of 1.1x is worth a...New Risk • May 23New major risk - Revenue and earnings growthEarnings have declined by 29% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 29% per year over the past 5 years. Minor Risk Market cap is less than US$100m (₩60.4b market cap, or US$44.0m).Reported Earnings • Mar 14Full year 2024 earnings released: ₩191 loss per share (vs ₩8.00 profit in FY 2023)Full year 2024 results: ₩191 loss per share (down from ₩8.00 profit in FY 2023). Revenue: ₩53.8b (down 19% from FY 2023). Net loss: ₩10.8b (down ₩11.3b from profit in FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 106 percentage points per year, which is a significant difference in performance.공시 • Feb 12SANGBO Corp., Annual General Meeting, Mar 26, 2025SANGBO Corp., Annual General Meeting, Mar 26, 2025, at 09:01 Tokyo Standard Time. Location: auditorium, 50, daeseomyeong-ro, tongjin-eup, gyeonggi-do, gimpo South Korea분석 기사 • Dec 14SANGBO Corp. (KOSDAQ:027580) Stock Rockets 27% As Investors Are Less Pessimistic Than ExpectedSANGBO Corp. ( KOSDAQ:027580 ) shares have had a really impressive month, gaining 27% after a shaky period beforehand...New Risk • Dec 09New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.9% average weekly change). Market cap is less than US$100m (₩63.6b market cap, or US$44.4m).New Risk • Dec 07New minor risk - Financial data availabilityLess than 3 years of financial data is available. This is considered a minor risk. If the company has been trading for less than 3 years, then it has not had the opportunity to establish a long-term track record. This makes it difficult for investors to assess the true growth potential, sustainability and resilience of the business under different economic conditions. Currently, the following risks have been identified for the company: Minor Risks Less than 3 years of financial data is available. Market cap is less than US$100m (₩72.5b market cap, or US$51.0m).분석 기사 • Nov 12Is SANGBO (KOSDAQ:027580) Using Debt Sensibly?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Reported Earnings • Aug 17Second quarter 2024 earnings released: EPS: ₩22.00 (vs ₩31.00 in 2Q 2023)Second quarter 2024 results: EPS: ₩22.00 (down from ₩31.00 in 2Q 2023). Revenue: ₩15.5b (down 10% from 2Q 2023). Net income: ₩1.24b (down 31% from 2Q 2023). Profit margin: 8.0% (down from 10% in 2Q 2023). Over the last 3 years on average, earnings per share has fallen by 53% per year but the company’s share price has only fallen by 11% per year, which means it has not declined as severely as earnings.Buy Or Sell Opportunity • May 17Now 23% overvaluedOver the last 90 days, the stock has fallen 11% to ₩1,868. The fair value is estimated to be ₩1,524, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 34% over the last 3 years. Earnings per share has declined by 25%.Buy Or Sell Opportunity • Apr 27Now 20% overvaluedThe stock has been flat over the last 90 days, currently trading at ₩1,840. The fair value is estimated to be ₩1,532, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 34% over the last 3 years. Earnings per share has declined by 25%.공시 • Apr 09SANGBO Corp. (KOSDAQ:A027580) announces an Equity Buyback for KRW 1,500 million worth of its shares.SANGBO Corp. (KOSDAQ:A027580) announces a share repurchase program. Under the program, the company will repurchase up to KRW 1,500 million worth of its shares pursuant to a contract with KB Securities Co., Ltd. The purpose of the program is to improve shareholder value and to stabilize stock price. The program will expire on October 8, 2024. As of April 7, 2024, the company had 1,992,650 shares in treasury within scope available for dividend and had 2,022 shares in treasury through other repurchase.Reported Earnings • Mar 19Full year 2023 earnings released: EPS: ₩8.00 (vs ₩67.43 in FY 2022)Full year 2023 results: EPS: ₩8.00 (down from ₩67.43 in FY 2022). Revenue: ₩66.2b (down 1.9% from FY 2022). Net income: ₩438.5m (down 89% from FY 2022). Profit margin: 0.7% (down from 5.9% in FY 2022). Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings.New Risk • Feb 20New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.1% average weekly change). Market cap is less than US$100m (₩112.9b market cap, or US$84.7m).Reported Earnings • Nov 19Third quarter 2023 earnings released: EPS: ₩44.00 (vs ₩59.03 in 3Q 2022)Third quarter 2023 results: EPS: ₩44.00 (down from ₩59.03 in 3Q 2022). Revenue: ₩17.4b (up 12% from 3Q 2022). Net income: ₩2.53b (down 26% from 3Q 2022). Profit margin: 15% (down from 22% in 3Q 2022). Over the last 3 years on average, earnings per share has fallen by 3% per year but the company’s share price has increased by 11% per year, which means it is well ahead of earnings.Valuation Update With 7 Day Price Move • Aug 23Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₩1,640, the stock trades at a trailing P/E ratio of 49.4x. Average trailing P/E is 15x in the Chemicals industry in South Korea. Total returns to shareholders of 30% over the past three years.Valuation Update With 7 Day Price Move • Jul 26Investor sentiment deteriorates as stock falls 22%After last week's 22% share price decline to ₩1,640, the stock trades at a trailing P/E ratio of 49.4x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total returns to shareholders of 59% over the past three years.New Risk • Jun 23New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 11% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (11% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (3.0% net profit margin).Valuation Update With 7 Day Price Move • Jun 22Investor sentiment improves as stock rises 25%After last week's 25% share price gain to ₩1,966, the stock trades at a trailing P/E ratio of 59.3x. Average trailing P/E is 15x in the Chemicals industry in South Korea. Total returns to shareholders of 99% over the past three years.Valuation Update With 7 Day Price Move • Mar 30Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₩1,614, the stock trades at a trailing P/E ratio of 23.8x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total returns to shareholders of 134% over the past three years.Reported Earnings • Mar 14Full year 2022 earnings released: EPS: ₩67.43 (vs ₩82.02 in FY 2021)Full year 2022 results: EPS: ₩67.43 (down from ₩82.02 in FY 2021). Revenue: ₩67.4b (down 6.9% from FY 2021). Net income: ₩4.00b (down 1.6% from FY 2021). Profit margin: 5.9% (up from 5.6% in FY 2021). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 106% per year but the company’s share price has only increased by 24% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Jun 23Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to ₩1,420, the stock trades at a trailing P/E ratio of 34.3x. Average trailing P/E is 12x in the Chemicals industry in South Korea. Total loss to shareholders of 1.3% over the past three years.Buying Opportunity • Mar 07Now 22% undervalued after recent price dropOver the last 90 days, the stock is down 11%. The fair value is estimated to be ₩2,210, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 34% per annum over the last 3 years. The company has become profitable over the last 3 years.Reported Earnings • Nov 15Third quarter 2021 earnings released: EPS ₩60.00 (vs ₩17.00 in 3Q 2020)The company reported a decent third quarter result with improved earnings and profit margins, although revenues were weaker. Third quarter 2021 results: Revenue: ₩33.0b (down 16% from 3Q 2020). Net income: ₩3.01b (up 282% from 3Q 2020). Profit margin: 9.1% (up from 2.0% in 3Q 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 104% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Jun 23Investor sentiment improved over the past weekAfter last week's 28% share price gain to ₩2,665, the stock trades at a trailing P/E ratio of 30.8x. Average trailing P/E is 21x in the Chemicals industry in South Korea. Total returns to shareholders of 47% over the past three years.Valuation Update With 7 Day Price Move • Jun 02Investor sentiment improved over the past weekAfter last week's 18% share price gain to ₩1,955, the stock trades at a trailing P/E ratio of 22.7x. Average trailing P/E is 20x in the Chemicals industry in South Korea. Total returns to shareholders of 5.0% over the past three years.Reported Earnings • May 16First quarter 2021 earnings released: EPS ₩18.00 (vs ₩3.00 loss in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: ₩34.0b (up 17% from 1Q 2020). Net income: ₩851.5m (up ₩969.3m from 1Q 2020). Profit margin: 2.5% (up from net loss in 1Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 53% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings.분석 기사 • Apr 14Returns At SANGBO (KOSDAQ:027580) Are On The Way UpThere are a few key trends to look for if we want to identify the next multi-bagger. One common approach is to try and...분석 기사 • Mar 19SANGBO (KOSDAQ:027580) Has A Somewhat Strained Balance SheetThe external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...공시 • Feb 22SANGBO Corp., Annual General Meeting, Mar 24, 2021SANGBO Corp., Annual General Meeting, Mar 24, 2021, at 09:00 Korea Standard Time.Is New 90 Day High Low • Feb 08New 90-day high: ₩1,530The company is up 18% from its price of ₩1,300 on 10 November 2020. The South Korean market is up 25% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 28% over the same period.분석 기사 • Dec 09SANGBO (KOSDAQ:027580) Takes On Some Risk With Its Use Of DebtWarren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...Is New 90 Day High Low • Dec 01New 90-day high: ₩1,490The company is up 3.0% from its price of ₩1,445 on 02 September 2020. The South Korean market is up 10.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 12% over the same period.Reported Earnings • Nov 13Third quarter 2020 earnings released: ₩4.17 loss per shareThe company reported a solid third quarter result with reduced losses and improved revenues and control over expenses. Third quarter 2020 results: Revenue: ₩15.5b (up 12% from 3Q 2019). Net loss: ₩198.9m (loss narrowed 91% from 3Q 2019). Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 12% per year, which means it is significantly lagging earnings.매출 및 비용 세부 내역SANGBO가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이KOSDAQ:A027580 매출, 비용 및 순이익 (KRW Millions)날짜매출순이익일반관리비연구개발비31 Dec 2550,105-12,8829,9484,73130 Sep 2550,686-15,9999,9756,94030 Jun 2552,450-15,71110,2646,89531 Mar 2552,741-12,75010,9806,33231 Dec 2453,827-10,81912,5835,92030 Sep 2458,204-4,16912,8331,76630 Jun 2461,105-59312,6611,71931 Mar 2462,843-2812,1101,84431 Dec 2366,15743810,6872,02130 Sep 2366,620-43210,2202,75630 Jun 2364,81846010,0322,64531 Mar 2365,4901,9569,4822,47531 Dec 2267,4124,0039,4362,47030 Sep 2225,88410,7576,0542,28830 Jun 2243,30610,3385,6712,23831 Mar 2256,8285,2626,4702,26831 Dec 2172,3894,0697,4722,17830 Sep 21131,7361,95110,1922,25130 Jun 21137,893-26910,4812,16831 Mar 21134,9364,1959,0542,39531 Dec 20130,1143,2268,3672,41730 Sep 20177,05783411,1162,55830 Jun 20151,812-2,12810,9592,80631 Mar 20135,818-9,12811,4292,62931 Dec 19118,221-10,36110,4672,69730 Sep 19-8,735-21,1117,9742,59730 Jun 1914,891-32,0728,4342,58831 Mar 1934,617-32,61211,2052,40431 Dec 1852,698-31,35011,4692,46130 Sep 18126,120-17,64910,8842,13330 Jun 18126,644-4,89311,0071,60831 Mar 18127,917-1,8529,0201,32031 Dec 17127,780-5,88010,6711,07030 Sep 17133,426-14,86012,1141,36530 Jun 17136,313-19,30413,6211,64831 Mar 17139,239-20,25115,9642,05931 Dec 16151,682-20,25716,2522,20130 Sep 16166,336-16,35318,0392,16330 Jun 16170,687-10,72320,4951,65731 Mar 16177,325-9,42618,8291,88531 Dec 15178,636-5,22019,0972,14830 Sep 15175,565-5,72020,7141,96030 Jun 15189,906-5,59020,1921,960양질의 수익: A027580 은(는) 현재 수익성이 없습니다.이익 마진 증가: A027580는 현재 수익성이 없습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: A027580은 수익성이 없으며 지난 5년 동안 손실이 연평균 71.8% 증가했습니다.성장 가속화: 현재 수익성이 없어 지난 1년간 A027580의 수익 성장률을 5년 평균과 비교할 수 없습니다.수익 대 산업: A027580은 수익성이 없어 지난 해 수익 성장률을 Chemicals 업계(-3.2%)와 비교하기 어렵습니다.자기자본이익률높은 ROE: A027580는 현재 수익성이 없으므로 자본 수익률이 음수(-30.14%)입니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YMaterials 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/22 09:42종가2026/05/22 00:00수익2025/12/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스SANGBO Corp.는 1명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Jeong LeeEugene Investment & Securities Co Ltd.
Reported Earnings • Mar 17Full year 2025 earnings released: ₩229 loss per share (vs ₩191 loss in FY 2024)Full year 2025 results: ₩229 loss per share (further deteriorated from ₩191 loss in FY 2024). Revenue: ₩50.1b (down 6.9% from FY 2024). Net loss: ₩12.9b (loss widened 19% from FY 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 87 percentage points per year, which is a significant difference in performance.
Reported Earnings • Mar 14Full year 2024 earnings released: ₩191 loss per share (vs ₩8.00 profit in FY 2023)Full year 2024 results: ₩191 loss per share (down from ₩8.00 profit in FY 2023). Revenue: ₩53.8b (down 19% from FY 2023). Net loss: ₩10.8b (down ₩11.3b from profit in FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 106 percentage points per year, which is a significant difference in performance.
Reported Earnings • Aug 17Second quarter 2024 earnings released: EPS: ₩22.00 (vs ₩31.00 in 2Q 2023)Second quarter 2024 results: EPS: ₩22.00 (down from ₩31.00 in 2Q 2023). Revenue: ₩15.5b (down 10% from 2Q 2023). Net income: ₩1.24b (down 31% from 2Q 2023). Profit margin: 8.0% (down from 10% in 2Q 2023). Over the last 3 years on average, earnings per share has fallen by 53% per year but the company’s share price has only fallen by 11% per year, which means it has not declined as severely as earnings.
Reported Earnings • Mar 19Full year 2023 earnings released: EPS: ₩8.00 (vs ₩67.43 in FY 2022)Full year 2023 results: EPS: ₩8.00 (down from ₩67.43 in FY 2022). Revenue: ₩66.2b (down 1.9% from FY 2022). Net income: ₩438.5m (down 89% from FY 2022). Profit margin: 0.7% (down from 5.9% in FY 2022). Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings.
Reported Earnings • Nov 19Third quarter 2023 earnings released: EPS: ₩44.00 (vs ₩59.03 in 3Q 2022)Third quarter 2023 results: EPS: ₩44.00 (down from ₩59.03 in 3Q 2022). Revenue: ₩17.4b (up 12% from 3Q 2022). Net income: ₩2.53b (down 26% from 3Q 2022). Profit margin: 15% (down from 22% in 3Q 2022). Over the last 3 years on average, earnings per share has fallen by 3% per year but the company’s share price has increased by 11% per year, which means it is well ahead of earnings.
Reported Earnings • Mar 14Full year 2022 earnings released: EPS: ₩67.43 (vs ₩82.02 in FY 2021)Full year 2022 results: EPS: ₩67.43 (down from ₩82.02 in FY 2021). Revenue: ₩67.4b (down 6.9% from FY 2021). Net income: ₩4.00b (down 1.6% from FY 2021). Profit margin: 5.9% (up from 5.6% in FY 2021). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 106% per year but the company’s share price has only increased by 24% per year, which means it is significantly lagging earnings growth.
New Risk • May 19New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 13% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 72% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (13% average weekly change). Market cap is less than US$100m (₩25.5b market cap, or US$16.9m).
Reported Earnings • Mar 17Full year 2025 earnings released: ₩229 loss per share (vs ₩191 loss in FY 2024)Full year 2025 results: ₩229 loss per share (further deteriorated from ₩191 loss in FY 2024). Revenue: ₩50.1b (down 6.9% from FY 2024). Net loss: ₩12.9b (loss widened 19% from FY 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 87 percentage points per year, which is a significant difference in performance.
공시 • Feb 20SANGBO Corp., Annual General Meeting, Mar 26, 2026SANGBO Corp., Annual General Meeting, Mar 26, 2026, at 09:01 Tokyo Standard Time. Location: auditorium, 50, daeseomyeong-ro, tongjin-eup, gyeonggi-do, gimpo South Korea
분석 기사 • Jan 07The Market Lifts SANGBO Corp. (KOSDAQ:027580) Shares 26% But It Can Do MoreSANGBO Corp. ( KOSDAQ:027580 ) shareholders would be excited to see that the share price has had a great month, posting...
New Risk • Jan 07New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 9.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 69% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (9.8% average weekly change). Market cap is less than US$100m (₩54.4b market cap, or US$37.6m).
분석 기사 • Nov 03Is SANGBO (KOSDAQ:027580) Using Too Much Debt?The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
분석 기사 • Jul 22SANGBO Corp.'s (KOSDAQ:027580) Share Price Could Signal Some RiskThere wouldn't be many who think SANGBO Corp.'s ( KOSDAQ:027580 ) price-to-sales (or "P/S") ratio of 1.1x is worth a...
New Risk • May 23New major risk - Revenue and earnings growthEarnings have declined by 29% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 29% per year over the past 5 years. Minor Risk Market cap is less than US$100m (₩60.4b market cap, or US$44.0m).
Reported Earnings • Mar 14Full year 2024 earnings released: ₩191 loss per share (vs ₩8.00 profit in FY 2023)Full year 2024 results: ₩191 loss per share (down from ₩8.00 profit in FY 2023). Revenue: ₩53.8b (down 19% from FY 2023). Net loss: ₩10.8b (down ₩11.3b from profit in FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 106 percentage points per year, which is a significant difference in performance.
공시 • Feb 12SANGBO Corp., Annual General Meeting, Mar 26, 2025SANGBO Corp., Annual General Meeting, Mar 26, 2025, at 09:01 Tokyo Standard Time. Location: auditorium, 50, daeseomyeong-ro, tongjin-eup, gyeonggi-do, gimpo South Korea
분석 기사 • Dec 14SANGBO Corp. (KOSDAQ:027580) Stock Rockets 27% As Investors Are Less Pessimistic Than ExpectedSANGBO Corp. ( KOSDAQ:027580 ) shares have had a really impressive month, gaining 27% after a shaky period beforehand...
New Risk • Dec 09New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.9% average weekly change). Market cap is less than US$100m (₩63.6b market cap, or US$44.4m).
New Risk • Dec 07New minor risk - Financial data availabilityLess than 3 years of financial data is available. This is considered a minor risk. If the company has been trading for less than 3 years, then it has not had the opportunity to establish a long-term track record. This makes it difficult for investors to assess the true growth potential, sustainability and resilience of the business under different economic conditions. Currently, the following risks have been identified for the company: Minor Risks Less than 3 years of financial data is available. Market cap is less than US$100m (₩72.5b market cap, or US$51.0m).
분석 기사 • Nov 12Is SANGBO (KOSDAQ:027580) Using Debt Sensibly?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Reported Earnings • Aug 17Second quarter 2024 earnings released: EPS: ₩22.00 (vs ₩31.00 in 2Q 2023)Second quarter 2024 results: EPS: ₩22.00 (down from ₩31.00 in 2Q 2023). Revenue: ₩15.5b (down 10% from 2Q 2023). Net income: ₩1.24b (down 31% from 2Q 2023). Profit margin: 8.0% (down from 10% in 2Q 2023). Over the last 3 years on average, earnings per share has fallen by 53% per year but the company’s share price has only fallen by 11% per year, which means it has not declined as severely as earnings.
Buy Or Sell Opportunity • May 17Now 23% overvaluedOver the last 90 days, the stock has fallen 11% to ₩1,868. The fair value is estimated to be ₩1,524, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 34% over the last 3 years. Earnings per share has declined by 25%.
Buy Or Sell Opportunity • Apr 27Now 20% overvaluedThe stock has been flat over the last 90 days, currently trading at ₩1,840. The fair value is estimated to be ₩1,532, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 34% over the last 3 years. Earnings per share has declined by 25%.
공시 • Apr 09SANGBO Corp. (KOSDAQ:A027580) announces an Equity Buyback for KRW 1,500 million worth of its shares.SANGBO Corp. (KOSDAQ:A027580) announces a share repurchase program. Under the program, the company will repurchase up to KRW 1,500 million worth of its shares pursuant to a contract with KB Securities Co., Ltd. The purpose of the program is to improve shareholder value and to stabilize stock price. The program will expire on October 8, 2024. As of April 7, 2024, the company had 1,992,650 shares in treasury within scope available for dividend and had 2,022 shares in treasury through other repurchase.
Reported Earnings • Mar 19Full year 2023 earnings released: EPS: ₩8.00 (vs ₩67.43 in FY 2022)Full year 2023 results: EPS: ₩8.00 (down from ₩67.43 in FY 2022). Revenue: ₩66.2b (down 1.9% from FY 2022). Net income: ₩438.5m (down 89% from FY 2022). Profit margin: 0.7% (down from 5.9% in FY 2022). Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings.
New Risk • Feb 20New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.1% average weekly change). Market cap is less than US$100m (₩112.9b market cap, or US$84.7m).
Reported Earnings • Nov 19Third quarter 2023 earnings released: EPS: ₩44.00 (vs ₩59.03 in 3Q 2022)Third quarter 2023 results: EPS: ₩44.00 (down from ₩59.03 in 3Q 2022). Revenue: ₩17.4b (up 12% from 3Q 2022). Net income: ₩2.53b (down 26% from 3Q 2022). Profit margin: 15% (down from 22% in 3Q 2022). Over the last 3 years on average, earnings per share has fallen by 3% per year but the company’s share price has increased by 11% per year, which means it is well ahead of earnings.
Valuation Update With 7 Day Price Move • Aug 23Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₩1,640, the stock trades at a trailing P/E ratio of 49.4x. Average trailing P/E is 15x in the Chemicals industry in South Korea. Total returns to shareholders of 30% over the past three years.
Valuation Update With 7 Day Price Move • Jul 26Investor sentiment deteriorates as stock falls 22%After last week's 22% share price decline to ₩1,640, the stock trades at a trailing P/E ratio of 49.4x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total returns to shareholders of 59% over the past three years.
New Risk • Jun 23New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 11% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (11% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (3.0% net profit margin).
Valuation Update With 7 Day Price Move • Jun 22Investor sentiment improves as stock rises 25%After last week's 25% share price gain to ₩1,966, the stock trades at a trailing P/E ratio of 59.3x. Average trailing P/E is 15x in the Chemicals industry in South Korea. Total returns to shareholders of 99% over the past three years.
Valuation Update With 7 Day Price Move • Mar 30Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₩1,614, the stock trades at a trailing P/E ratio of 23.8x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total returns to shareholders of 134% over the past three years.
Reported Earnings • Mar 14Full year 2022 earnings released: EPS: ₩67.43 (vs ₩82.02 in FY 2021)Full year 2022 results: EPS: ₩67.43 (down from ₩82.02 in FY 2021). Revenue: ₩67.4b (down 6.9% from FY 2021). Net income: ₩4.00b (down 1.6% from FY 2021). Profit margin: 5.9% (up from 5.6% in FY 2021). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 106% per year but the company’s share price has only increased by 24% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Jun 23Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to ₩1,420, the stock trades at a trailing P/E ratio of 34.3x. Average trailing P/E is 12x in the Chemicals industry in South Korea. Total loss to shareholders of 1.3% over the past three years.
Buying Opportunity • Mar 07Now 22% undervalued after recent price dropOver the last 90 days, the stock is down 11%. The fair value is estimated to be ₩2,210, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 34% per annum over the last 3 years. The company has become profitable over the last 3 years.
Reported Earnings • Nov 15Third quarter 2021 earnings released: EPS ₩60.00 (vs ₩17.00 in 3Q 2020)The company reported a decent third quarter result with improved earnings and profit margins, although revenues were weaker. Third quarter 2021 results: Revenue: ₩33.0b (down 16% from 3Q 2020). Net income: ₩3.01b (up 282% from 3Q 2020). Profit margin: 9.1% (up from 2.0% in 3Q 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 104% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Jun 23Investor sentiment improved over the past weekAfter last week's 28% share price gain to ₩2,665, the stock trades at a trailing P/E ratio of 30.8x. Average trailing P/E is 21x in the Chemicals industry in South Korea. Total returns to shareholders of 47% over the past three years.
Valuation Update With 7 Day Price Move • Jun 02Investor sentiment improved over the past weekAfter last week's 18% share price gain to ₩1,955, the stock trades at a trailing P/E ratio of 22.7x. Average trailing P/E is 20x in the Chemicals industry in South Korea. Total returns to shareholders of 5.0% over the past three years.
Reported Earnings • May 16First quarter 2021 earnings released: EPS ₩18.00 (vs ₩3.00 loss in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: ₩34.0b (up 17% from 1Q 2020). Net income: ₩851.5m (up ₩969.3m from 1Q 2020). Profit margin: 2.5% (up from net loss in 1Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 53% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings.
분석 기사 • Apr 14Returns At SANGBO (KOSDAQ:027580) Are On The Way UpThere are a few key trends to look for if we want to identify the next multi-bagger. One common approach is to try and...
분석 기사 • Mar 19SANGBO (KOSDAQ:027580) Has A Somewhat Strained Balance SheetThe external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
공시 • Feb 22SANGBO Corp., Annual General Meeting, Mar 24, 2021SANGBO Corp., Annual General Meeting, Mar 24, 2021, at 09:00 Korea Standard Time.
Is New 90 Day High Low • Feb 08New 90-day high: ₩1,530The company is up 18% from its price of ₩1,300 on 10 November 2020. The South Korean market is up 25% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 28% over the same period.
분석 기사 • Dec 09SANGBO (KOSDAQ:027580) Takes On Some Risk With Its Use Of DebtWarren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...
Is New 90 Day High Low • Dec 01New 90-day high: ₩1,490The company is up 3.0% from its price of ₩1,445 on 02 September 2020. The South Korean market is up 10.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 12% over the same period.
Reported Earnings • Nov 13Third quarter 2020 earnings released: ₩4.17 loss per shareThe company reported a solid third quarter result with reduced losses and improved revenues and control over expenses. Third quarter 2020 results: Revenue: ₩15.5b (up 12% from 3Q 2019). Net loss: ₩198.9m (loss narrowed 91% from 3Q 2019). Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 12% per year, which means it is significantly lagging earnings.